Open Access
This journal is a peer reviewed, fully open access journal owned by FAR Publishing Limited. FAR Publishing Limited retains copyright of the overall compiled journal and the compiled issues. The article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication.
To provide open access, this journal has an open access fee (also known as an Article Processing Charge, APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. The open access publication fee for this journal is USD 2100, plus taxes.
Refund Policy
This refund policy outlines the terms and conditions under which refunds or credits may be issued for articles published in our journals.
Once an article has been submitted into the publication workflow, APCs (Article Processing Charge) are deemed non-refundable. Nonetheless, should an oversight by our publication team result in the article's failure to be published, the editorial board retains the right to approve a refund on a case-by-case basis.
We recommend that you carefully review these conditions prior to submitting your manuscript for publication.
Peer review under the responsibility of Editorial Board of Current Pharmaceutical Analysis.
Access Rights
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute.
User Rights
A CC user license manages the reuse of the article. Articles will be published under following license:
Creative Commons Attribution 4.0 (CC-BY)
Let others to copy, to create extracts, abstracts and new works from the Article, to alter and revise the Article, and to make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by/4.0/
Author Rights
For open access publishing, this journal uses a licensing agreement. For the single article, Authors will retain copyright alongside scholarly usage rights, and KeAi Communications Co., Ltd. and FAR Publishing Limited will be granted non-exclusive publishing and distribution rights.
Publishing Schedule
This journal is published 10 issues per year.
Learn More about:
Contact Detail
Jerry Xu
Managing Editor
Email: jerry_xu@fargroups.com